Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2018 03:10 ET | Source: Veritas Pharma Inc.

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the Company and its...
January 10, 2018 17:02 ET | Source: Veritas Pharma Inc.

Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain

VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm,...
January 09, 2018 03:05 ET | Source: Veritas Pharma Inc.

Veritas Pharma Provides Comment on U.S. Attorney General Jeff Sessions Memo

VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) and (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the...
January 04, 2018 17:24 ET | Source: Veritas Pharma Inc.

Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders

VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
January 02, 2018 03:05 ET | Source: Veritas Pharma Inc.

Dr. Brian O’Connor Joins Veritas Pharma Advisory Board

VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor,...
December 29, 2017 03:05 ET | Source: Veritas Pharma Inc.

Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility

VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy...
December 28, 2017 03:05 ET | Source: Veritas Pharma Inc.

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that Health Canada has issued its...
December 08, 2017 03:05 ET | Source: Veritas Pharma Inc.

Veritas Hires Medical Director to Advise Physicians & Regulators on the Application of Cannevert’s Experimental Results with Cannabis to Clinical Practice & Public Policy

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the hiring of Dr. M....
December 05, 2017 03:05 ET | Source: Veritas Pharma Inc.

Veritas’ Research Arm Cannevert Signs a Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico

VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
November 29, 2017 16:30 ET | Source: Veritas Pharma Inc.

Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board

VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob”...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right